trending Market Intelligence /marketintelligence/en/news-insights/trending/KNVPRHCiRi0vTUybFFxgsQ2 content esgSubNav
In This List

Novelion Therapeutics completes reverse stock split

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Novelion Therapeutics completes reverse stock split

Novelion Therapeutics Inc. completed a planned 1-to-5 reverse stock split.

The company will now have 18,530,700 shares issued and outstanding with trading to resume on Nasdaq on Dec. 19 and the Toronto Stock Exchange on Dec. 21.